171 related articles for article (PubMed ID: 15805118)
1. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells.
Sugita H; Fujimoto M; Yasukawa T; Shimizu N; Sugita M; Yasuhara S; Martyn JA; Kaneki M
J Biol Chem; 2005 Apr; 280(14):14203-11. PubMed ID: 15805118
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta.
Tanioka T; Tamura Y; Fukaya M; Shinozaki S; Mao J; Kim M; Shimizu N; Kitamura T; Kaneki M
J Biol Chem; 2011 Aug; 286(33):29388-29396. PubMed ID: 21700708
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase deficiency ameliorates skeletal muscle insulin resistance but does not alter unexpected lower blood glucose levels after burn injury in C57BL/6 mice.
Sugita M; Sugita H; Kim M; Mao J; Yasuda Y; Habiro M; Shinozaki S; Yasuhara S; Shimizu N; Martyn JA; Kaneki M
Metabolism; 2012 Jan; 61(1):127-36. PubMed ID: 21816442
[TBL] [Abstract][Full Text] [Related]
4. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice.
Fujimoto M; Shimizu N; Kunii K; Martyn JA; Ueki K; Kaneki M
Diabetes; 2005 May; 54(5):1340-8. PubMed ID: 15855318
[TBL] [Abstract][Full Text] [Related]
5. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice.
Carvalho-Filho MA; Ueno M; Carvalheira JB; Velloso LA; Saad MJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E476-82. PubMed ID: 16638822
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein.
Sugita H; Kaneki M; Furuhashi S; Hirota M; Takamori H; Baba H
Mol Cancer Res; 2010 Aug; 8(8):1152-63. PubMed ID: 20663861
[TBL] [Abstract][Full Text] [Related]
7. Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt.
Carvalho-Filho MA; Ropelle ER; Pauli RJ; Cintra DE; Tsukumo DM; Silveira LR; Curi R; Carvalheira JB; Velloso LA; Saad MJ
Diabetologia; 2009 Nov; 52(11):2425-34. PubMed ID: 19730809
[TBL] [Abstract][Full Text] [Related]
8. S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance.
Yasukawa T; Tokunaga E; Ota H; Sugita H; Martyn JA; Kaneki M
J Biol Chem; 2005 Mar; 280(9):7511-8. PubMed ID: 15632167
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin mediated-iNOS induction causes insulin resistance via ONOO⁻ induced tyrosine nitration of IRS-1 in skeletal muscle.
Pilon G; Charbonneau A; White PJ; Dallaire P; Perreault M; Kapur S; Marette A
PLoS One; 2010 Dec; 5(12):e15912. PubMed ID: 21206533
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells.
Montagnani M; Ravichandran LV; Chen H; Esposito DL; Quon MJ
Mol Endocrinol; 2002 Aug; 16(8):1931-42. PubMed ID: 12145346
[TBL] [Abstract][Full Text] [Related]
11. Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice.
Shinozaki S; Choi CS; Shimizu N; Yamada M; Kim M; Zhang T; Shiota G; Dong HH; Kim YB; Kaneki M
J Biol Chem; 2011 Oct; 286(40):34959-75. PubMed ID: 21846719
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle.
Perreault M; Marette A
Nat Med; 2001 Oct; 7(10):1138-43. PubMed ID: 11590438
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway.
Kaliman P; Canicio J; Testar X; Palacín M; Zorzano A
J Biol Chem; 1999 Jun; 274(25):17437-44. PubMed ID: 10364173
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse.
Kerouz NJ; Hörsch D; Pons S; Kahn CR
J Clin Invest; 1997 Dec; 100(12):3164-72. PubMed ID: 9399964
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2.
Rui L; Fisher TL; Thomas J; White MF
J Biol Chem; 2001 Oct; 276(43):40362-7. PubMed ID: 11546773
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
17. Nitrosative stress and pathogenesis of insulin resistance.
Kaneki M; Shimizu N; Yamada D; Chang K
Antioxid Redox Signal; 2007 Mar; 9(3):319-29. PubMed ID: 17184170
[TBL] [Abstract][Full Text] [Related]
18. beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.
Usui I; Imamura T; Huang J; Satoh H; Shenoy SK; Lefkowitz RJ; Hupfeld CJ; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(20):8929-37. PubMed ID: 15456867
[TBL] [Abstract][Full Text] [Related]
19. Tissue inflammation and nitric oxide-mediated alterations in cardiovascular function are major determinants of endotoxin-induced insulin resistance.
House LM; Morris RT; Barnes TM; Lantier L; Cyphert TJ; McGuinness OP; Otero YF
Cardiovasc Diabetol; 2015 May; 14():56. PubMed ID: 25986700
[TBL] [Abstract][Full Text] [Related]
20. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.
Haruta T; Uno T; Kawahara J; Takano A; Egawa K; Sharma PM; Olefsky JM; Kobayashi M
Mol Endocrinol; 2000 Jun; 14(6):783-94. PubMed ID: 10847581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
